20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with puromycin aminonucleoside in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (puromycin aminonucleoside) | Trials (puromycin aminonucleoside) | Recent Studies (post-2010) (puromycin aminonucleoside) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 874 | 3 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCarthy, ET; Sharma, M; Sharma, R | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and puromycin aminonucleoside
| Article | Year |
|---|---|
Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier.
Topics: Animals; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Glomerular Filtration Rate; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Kidney Glomerulus; Male; Permeability; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley | 2005 |